At 6.4% CAGR, Middle East & Africa Colostrum Market is Projected to be Worth US$ 103.70 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa colostrum market was valued at US$ 63.30 million in 2023 and is expected to reach US$ 103.70 million by 2031, registering a CAGR of 6.4% from 2023 to 2031. Technological advancements in colostrum processing and rising demand for colostrum-based cosmetics and personal care products are among the critical factors attributed to drive the Middle East & Africa colostrum market growth.

Colostrum is significantly used in functional food & beverages, pharmaceuticals & nutraceuticals, animal nutrition, and personal care products through various manufacturing processes. Various technologies are used to preserve and protect the significant bioactive factors in colostrum. Thermal treatment methods and drying methods such as pasteurization and sterilization are commonly used technologies. Moreover, manufacturers are now adopting advanced technologies to develop high nutrient-enriched colostrum. Liposomal technology and nanotechnology are used to prepare colostrum for human consumption with numerous health benefits. Nanotechnology is the study of structures and materials on an ultra-small scale, and it has various applications in many fields, from the dairy industry to medicine. Nanotechnology can detect food pathogens, which ensures the food quality and safety. This technology is increasingly used in the food market due to its advantages, such as improving the shelf life of products, flavor, and texture of foods. Additionally, this technology provides significant advantages to avoid instability problems in preserving colostrum and its bioactive proteins. The stability of colostrum proteins, such as IgG, is crucial to preserving the bioactive potential of colostrum. Liposomal technology is a commonly used encapsulation method widely preferred in the cosmetic, pharmaceutical, and dairy industries. This advanced technology uses a liposome, a spherical vesicle including at least one lipid bilayer and phospholipids. Liposomes can have surface ligands to ensure the binding of various ligands. Liposomal technology has been used to preserve colostrum and increase its bioavailability for human health. The delivery of colostrum through the body with the reconstituted membrane phospholipids is far more effective than the colostrum without liposomal encapsulation, making the method more advanced than other conventional methods. Thus, technological advancements in colostrum processing are projected to open lucrative growth opportunities in the colostrum market worldwide.

On the contrary, the increasing veganism trend worldwide hampers the growth of Middle East & Africa colostrum market.

Based on form, the Middle East & Africa colostrum market is bifurcated into dry and liquid. The dry segment held 95.3% market share in 2023, amassing US$ 60.35 million. It is projected to garner US$ 98.99 million by 2031 to register 6.4% CAGR during 2023–2031.

In terms of category, the Middle East & Africa colostrum market is bifurcated into conventional and organic. The conventional segment held 89.3% share of Middle East & Africa colostrum market in 2023, amassing US$ 56.50 million. It is anticipated to garner US$ 92.19 million by 2031 to expand at 6.3% CAGR during 2023–2031.

By application, the Middle East & Africa colostrum market is segmented into pharmaceuticals and dietary supplements, food and beverages, animal nutrition, and personal care. The pharmaceuticals and dietary supplements segment held 50.7% share of Middle East & Africa colostrum market in 2023, amassing US$ 32.11 million. It is anticipated to garner US$ 53.72 million by 2031 to expand at 6.6% CAGR during 2023–2031.

By country, the Middle East & Africa colostrum market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 49.6% share of Middle East & Africa colostrum market in 2023. It was assessed at US$ 31.37 million in 2023 and is likely to hit US$ 50.18 million by 2031, registering a CAGR of 6.0% during 2023–2031.

Key players operating in the colostrum market are Titan Biotech Ltd, Pantheryx, Biodane Pharma A/S, Bionatin, Colostrum BioTec GmbH, Biostrum, Cure Nutraceutical PVT. LTD., INGREDIA s.r.o., I. Livanou IKE, and KERSIA GROUP, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com